ACLARIS THERAPEUTICS INC (ACRS)

US00461U1051 - Common Stock

1.16  -0.01 (-0.85%)

Buy % Consensus

71

ChartMill assigns a Buy % Consensus number of 71% to ACRS. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 1.84. This target is 58.28% above the current price.
ACRS was analyzed by 15 analysts. The buy percentage consensus is at 71. So analysts seem to be have mildly positive about ACRS.
In the previous month the buy percentage consensus was at a similar level.
ACRS was analyzed by 15 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 1.161.012.041.843.15 - -12.93% 75.86% 58.28% 171.55%
Up and Down Grades
Date Firm Action Rating
2024-01-22 HC Wainwright & Co. Downgrade Buy -> Neutral
2024-01-11 BTIG Downgrade Buy -> Neutral
2023-12-29 HC Wainwright & Co. Reiterate Buy -> Buy
2023-12-18 Stifel Maintains Hold -> Hold
2023-11-14 Cantor Fitzgerald Downgrade Overweight -> Neutral
2023-11-14 HC Wainwright & Co. Maintains Buy -> Buy
2023-11-13 William Blair Downgrade Outperform -> Market Perform
2023-11-13 Stifel Downgrade Buy -> Hold
2023-10-09 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-10-04 HC Wainwright & Co. Reiterate Buy -> Buy
2023-10-03 Evercore ISI Group Initiate Outperform
2023-09-19 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-09-19 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-14 Stifel Maintains Buy -> Buy
2023-08-08 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-14 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-07 BTIG Maintains Buy
2023-03-07 Goldman Sachs Maintains Buy
2023-03-07 HC Wainwright & Co. Maintains Buy
2023-02-24 HC Wainwright & Co. Reiterate Buy
2023-02-07 Cantor Fitzgerald Reiterate Overweight
2022-12-14 Stifel Initiate Buy
2022-12-01 Goldman Sachs Initiate Buy
2022-10-06 BTIG Initiate Buy
2021-06-16 HC Wainwright & Co. Maintains Buy
2021-06-15 Piper Sandler Initiate Overweight
2021-04-21 HC Wainwright & Co. Initiate Buy
2021-03-04 SVB Leerink Maintains Outperform